Clinical Translation of Tissue-engineered Constructs for Severe Leg Injuries

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2015 Jul 25

PMID 26207227

Citations 3

Authors

Nicolas LHeureux

Didier Letourneur

Affiliations

Soon will be listed here.

Citing Articles

Transcriptome profiling of a synergistic volumetric muscle loss repair strategy.

Roberts K, Kim J, Huynh T, Schluns J, Dunlap G, Hestekin J BMC Musculoskelet Disord. 2023; 24(1):321.

PMID: 37095469 PMC: 10124022. DOI: 10.1186/s12891-023-06401-1.

Disruptive technological advances in vascular access for dialysis: an overview.

Yeo W, Ng Q Pediatr Nephrol. 2017; 33(12):2221-2226.

PMID: 29188361 DOI: 10.1007/s00467-017-3853-7.

Strategies for functional bioscaffold-based skeletal muscle reconstruction.

Sicari B, Dziki J, Badylak S Ann Transl Med. 2015; 3(17):256.

PMID: 26605302 PMC: 4620105. DOI: 10.3978/j.issn.2305-5839.2015.09.45.

References

Corona B, Ward C, Baker H, Walters T, Christ G . Implantation of in vitro tissue engineered muscle repair constructs and bladder acellular matrices partially restore in vivo skeletal muscle function in a rat model of volumetric muscle loss injury. Tissue Eng Part A. 2013; 20(3-4):705-15. PMC: 4518882. DOI: 10.1089/ten.TEA.2012.0761. View

Turner N, Badylak J, Weber D, Badylak S . Biologic scaffold remodeling in a dog model of complex musculoskeletal injury. J Surg Res. 2012; 176(2):490-502. DOI: 10.1016/j.jss.2011.11.1029. View

Abed A, Deval B, Assoul N, Bataille I, Portes P, Louedec L . A biocompatible polysaccharide hydrogel-embedded polypropylene mesh for enhanced tissue integration in rats. Tissue Eng Part A. 2008; 14(4):519-27. DOI: 10.1089/tea.2007.0134. View

Faulk D, Londono R, Wolf M, Ranallo C, Carruthers C, Wildemann J . ECM hydrogel coating mitigates the chronic inflammatory response to polypropylene mesh. Biomaterials. 2014; 35(30):8585-95. PMC: 5942585. DOI: 10.1016/j.biomaterials.2014.06.057. View

Teodori L, Costa A, Marzio R, Perniconi B, Coletti D, Adamo S . Native extracellular matrix: a new scaffolding platform for repair of damaged muscle. Front Physiol. 2014; 5:218. PMC: 4058757. DOI: 10.3389/fphys.2014.00218. View

Corona B, Wu X, Ward C, McDaniel J, Rathbone C, Walters T . The promotion of a functional fibrosis in skeletal muscle with volumetric muscle loss injury following the transplantation of muscle-ECM. Biomaterials. 2013; 34(13):3324-35. DOI: 10.1016/j.biomaterials.2013.01.061. View

Juhas M, Bursac N . Engineering skeletal muscle repair. Curr Opin Biotechnol. 2013; 24(5):880-6. PMC: 3766474. DOI: 10.1016/j.copbio.2013.04.013. View

McAllister T, Maruszewski M, Garrido S, Wystrychowski W, Dusserre N, Marini A . Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet. 2009; 373(9673):1440-6. DOI: 10.1016/S0140-6736(09)60248-8. View

Chen X, Walters T . Muscle-derived decellularised extracellular matrix improves functional recovery in a rat latissimus dorsi muscle defect model. J Plast Reconstr Aesthet Surg. 2013; 66(12):1750-8. DOI: 10.1016/j.bjps.2013.07.037. View

10.

Ram-Liebig G, Bednarz J, Stuerzebecher B, Fahlenkamp D, Barbagli G, Romano G . Regulatory challenges for autologous tissue engineered products on their way from bench to bedside in Europe. Adv Drug Deliv Rev. 2014; 82-83:181-91. DOI: 10.1016/j.addr.2014.11.009. View

11.

Sicari B, Agrawal V, Siu B, Medberry C, Dearth C, Turner N . A murine model of volumetric muscle loss and a regenerative medicine approach for tissue replacement. Tissue Eng Part A. 2012; 18(19-20):1941-8. PMC: 3463275. DOI: 10.1089/ten.TEA.2012.0475. View

12.

Sicari B, Rubin J, Dearth C, Wolf M, Ambrosio F, Boninger M . An acellular biologic scaffold promotes skeletal muscle formation in mice and humans with volumetric muscle loss. Sci Transl Med. 2014; 6(234):234ra58. PMC: 5942588. DOI: 10.1126/scitranslmed.3008085. View

13.

Valentin J, Stewart-Akers A, Gilbert T, Badylak S . Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng Part A. 2009; 15(7):1687-94. PMC: 2792102. DOI: 10.1089/ten.tea.2008.0419. View

14.

Tsuchiya T, Sivarapatna A, Rocco K, Nanashima A, Nagayasu T, Niklason L . Future prospects for tissue engineered lung transplantation: decellularization and recellularization-based whole lung regeneration. Organogenesis. 2014; 10(2):196-207. PMC: 4154954. DOI: 10.4161/org.27846. View

15.

Garg K, Ward C, Rathbone C, Corona B . Transplantation of devitalized muscle scaffolds is insufficient for appreciable de novo muscle fiber regeneration after volumetric muscle loss injury. Cell Tissue Res. 2014; 358(3):857-73. DOI: 10.1007/s00441-014-2006-6. View

16.

Mertens J, Sugg K, Lee J, Larkin L . Engineering muscle constructs for the creation of functional engineered musculoskeletal tissue. Regen Med. 2013; 9(1):89-100. PMC: 4482104. DOI: 10.2217/rme.13.81. View

17.

Valentin J, Turner N, Gilbert T, Badylak S . Functional skeletal muscle formation with a biologic scaffold. Biomaterials. 2010; 31(29):7475-84. PMC: 2922042. DOI: 10.1016/j.biomaterials.2010.06.039. View

18.

Patterson J, Gilliland T, Maxfield M, Church S, Naito Y, Shinoka T . Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again. Regen Med. 2012; 7(3):409-19. PMC: 3384697. DOI: 10.2217/rme.12.12. View

19.

Meng F, Slivka P, Dearth C, Badylak S . Solubilized extracellular matrix from brain and urinary bladder elicits distinct functional and phenotypic responses in macrophages. Biomaterials. 2015; 46:131-40. DOI: 10.1016/j.biomaterials.2014.12.044. View

20.

Brown B, Sicari B, Badylak S . Rethinking regenerative medicine: a macrophage-centered approach. Front Immunol. 2014; 5:510. PMC: 4219501. DOI: 10.3389/fimmu.2014.00510. View